Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Cakar

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
Journal of the American Academy of Dermatology|November 2, 2013
Serum endocan levels as a marker of disease activity in patients with Behçet diseaseIlknur Balta, Sevket Balta, Ozgul Mustu Koryurek, et al.
Angiology|January 30, 2013
Carotid Intima Media Thickness and Its Association With Total Bilirubin Levels in Patients With Coronary Artery EctasiaSait Demirkol, Sevket Balta, Turgay Celik, et al.
Renal Failure|January 10, 2013
Amlodipine seems to be superior to valsartan in decreasing microalbuminuria in newly diagnosed hypertensive patients: a novel effect to be explained with hyperfiltration?Seyit Ahmet Ay, Mustafa Cakar, Murat Karaman, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 25, 2013
Carotid intima-media thickness in patients with slow coronary flow and its association with neutrophil-to-lymphocyte ratio: a preliminary reportFaruk Cingoz, Atila Iyisoy, Sait Demirkol, et al.
Renal Failure|April 9, 2013
Amlodipine increases vitamin D levels more than valsartan in newly diagnosed hypertensive patients: pointing to an additional effect on bone metabolism or a novel marker of inflammation?Seyit Ahmet Ay, Murat Karaman, Mustafa Cakar, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|December 4, 2012
An additional LDL-lowering effect of amlodipine; not only an antihypertensive?Zekeriya Arslan, Seyit Ahmet Ay, Murat Karaman, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 15, 2012
The comparative effects of valsartan and amlodipine on vascular microinflammation in newly diagnosed hypertensive patientsMurat Unlu, Murat Karaman, Seyit Ahmet Ay, et al.
Angiology|December 5, 2013
Asymmetric dimethylarginine and augmentation index in newly diagnosed patients with hypertensionMustafa Cakar, Fatih Bulucu, Murat Karaman, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 8, 2013
The comparative effects of valsartan and amlodipine on vWf levels and N/L ratio in patients with newly diagnosed hypertensionMurat Karaman, Sevket Balta, A Y Seyit Ahmet, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Journal of the American Academy of Dermatology|November 2, 2013
Serum endocan levels as a marker of disease activity in patients with Behçet diseaseIlknur Balta, Sevket Balta, Ozgul Mustu Koryurek, et al.
Angiology|January 30, 2013
Carotid Intima Media Thickness and Its Association With Total Bilirubin Levels in Patients With Coronary Artery EctasiaSait Demirkol, Sevket Balta, Turgay Celik, et al.
Renal Failure|January 10, 2013
Amlodipine seems to be superior to valsartan in decreasing microalbuminuria in newly diagnosed hypertensive patients: a novel effect to be explained with hyperfiltration?Seyit Ahmet Ay, Mustafa Cakar, Murat Karaman, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 25, 2013
Carotid intima-media thickness in patients with slow coronary flow and its association with neutrophil-to-lymphocyte ratio: a preliminary reportFaruk Cingoz, Atila Iyisoy, Sait Demirkol, et al.
Renal Failure|April 9, 2013
Amlodipine increases vitamin D levels more than valsartan in newly diagnosed hypertensive patients: pointing to an additional effect on bone metabolism or a novel marker of inflammation?Seyit Ahmet Ay, Murat Karaman, Mustafa Cakar, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|December 4, 2012
An additional LDL-lowering effect of amlodipine; not only an antihypertensive?Zekeriya Arslan, Seyit Ahmet Ay, Murat Karaman, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 15, 2012
The comparative effects of valsartan and amlodipine on vascular microinflammation in newly diagnosed hypertensive patientsMurat Unlu, Murat Karaman, Seyit Ahmet Ay, et al.
Angiology|December 5, 2013
Asymmetric dimethylarginine and augmentation index in newly diagnosed patients with hypertensionMustafa Cakar, Fatih Bulucu, Murat Karaman, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 8, 2013
The comparative effects of valsartan and amlodipine on vWf levels and N/L ratio in patients with newly diagnosed hypertensionMurat Karaman, Sevket Balta, A Y Seyit Ahmet, et al.
Pageof 12